Applications of urinary proteomics in biomarker discovery

被引:0
|
作者
Chen Shao
Yan Wang
YouHe Gao
机构
[1] Peking Union Medical College,National Key Laboratory of Medical Molecular Biology, Department of Physiology and Pathophysiology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences/School of Basic Medicine
来源
关键词
urine; proteomics; biomarker;
D O I
暂无
中图分类号
学科分类号
摘要
Urine is an important source of biomarkers. This article reviews current advances, major challenges, and future prospects in the field of urinary proteomics. Because the practical clinical problem is to distinguish diseases with similar symptoms, merely comparing samples from patients of a particular disease to those of healthy individuals is inadequate for finding biomarkers with sufficient diagnostic power. In addition, the variation of expression levels of urinary proteins among healthy individuals and individuals under different physiological conditions adds to the difficulty in identifying biomarkers. We propose that establishing the natural variation in urinary protein expression among a healthy population can serve as a reference to help identify protein abundance changes that are caused by disease, not by individual variations or physiological changes. We also discuss that comparing protein expression levels between urine and plasma may reveal the physiological function of the kidney and that may facilitate biomarker discovery. Finally, we propose that establishing a data-sharing platform for data collection and integrating results from all urinary biomarker studies will help promote the development of urinary proteomics.
引用
收藏
页码:409 / 417
页数:8
相关论文
共 50 条
  • [31] Urine proteomics in cardiovascular disease: advances in biomarker discovery and clinical applications
    Song, Xiaohong
    Chen, Zhaoran
    Zheng, Yuehong
    Wu, Jianqiang
    EXPERT REVIEW OF PROTEOMICS, 2024,
  • [32] Urinary biomarker discovery in gliomas using mass spectrometry-based clinical proteomics
    Wu J.
    Zhang J.
    Wei J.
    Zhao Y.
    Gao Y.
    Chinese Neurosurgical Journal, 6 (1)
  • [33] Urinary biomarker discovery in gliomas using mass spectrometry-based clinical proteomics
    Wu Jianqiang
    Zhang Jun
    Wei Jing
    Zhao Yuanli
    Gao Youhe
    中华神经外科杂志(英文), 2020, (02) : 82 - 91
  • [34] Metastatic Biomarker Discovery Through Proteomics
    Brinton, Lindsey T.
    Brentnall, Teresa A.
    Smith, Jeffrey A.
    Kelly, Kimberly A.
    CANCER GENOMICS & PROTEOMICS, 2012, 9 (06) : 345 - 355
  • [35] Application of proteomics in cancer biomarker discovery
    Raghavakaimal, S
    ONCOLOGY RESEARCH, 2006, 15 (10-12) : 457 - 457
  • [36] Biomarker discovery of nasopharyngeal carcinoma by proteomics
    Xiao, Liang
    Xiao, Ta
    Wang, Zhi-Ming
    Cho, William C. S.
    Xiao, Zhi-Qiang
    EXPERT REVIEW OF PROTEOMICS, 2014, 11 (02) : 215 - 225
  • [37] Proteomics techniques in protein biomarker discovery
    Babaei, Mahsa
    Kashanian, Soheila
    Lee, Huang-Teck
    Harding, Frances
    QUANTITATIVE BIOLOGY, 2024, 12 (01) : 53 - 69
  • [38] Proteomics in the forefront of cancer biomarker discovery
    Srivastava, S
    Srivastava, RG
    JOURNAL OF PROTEOME RESEARCH, 2005, 4 (04) : 1098 - 1103
  • [39] In vitro biomarker discovery for atherosclerosis by proteomics
    Fach, EM
    Garulacan, LA
    Gao, J
    Xiao, Q
    Storm, SM
    Dubaquie, YP
    Hefta, SA
    Opiteck, GJ
    MOLECULAR & CELLULAR PROTEOMICS, 2004, 3 (12) : 1200 - 1210
  • [40] Proteomics in prostate cancer biomarker discovery
    Larkin, Samantha E. T.
    Zeidan, Bashar
    Taylor, Matthew G.
    Bickers, Bridget
    Al-Ruwaili, Jamal
    Aukim-Hastie, Claire
    Townsend, Paul A.
    EXPERT REVIEW OF PROTEOMICS, 2010, 7 (01) : 93 - 102